Logo Medical XPRT
Companies
Products
Services
Software
Training
Applications
Sign in
List your business

Advertising options
  1. Home
  2. News
  3. muscle research
Show results for
Products

Companies

News
Articles
Downloads

Refine by
Date

  • Older

Muscle Research Articles & Analysis

4 news found

Zucara Therapeutics Expands ZT-01 Development Program to Type 2 Diabetes

Zucara Therapeutics Expands ZT-01 Development Program to Type 2 Diabetes

The development of ZT-01 for T2D will be supported, in part, by advisory services and up to $415,000 in non-dilutive research and development funding from the National Research Council of Canada Industrial Research Assistance Program (NRC IRAP). ...

ByZucara Therapeutics Inc.


Zucara Therapeutics Expands ZT-01 Development Program to Type 2 Diabetes

Zucara Therapeutics Expands ZT-01 Development Program to Type 2 Diabetes

The development of ZT-01 for T2D will be supported, in part, by advisory services and up to $415,000 in non-dilutive research and development funding from the National Research Council of Canada Industrial Research Assistance Program (NRC IRAP). ...

ByZucara Therapeutics Inc.


CardioWise Stretch Quantifier for Endocardial Engraved Zones (SQuEEZ) Receives Patents from Both the United States and the European Union

CardioWise Stretch Quantifier for Endocardial Engraved Zones (SQuEEZ) Receives Patents from Both the United States and the European Union

Both patents are entitled “Methods for Evaluating Regional Cardiac Function and Dyssynchrony from a Dynamic Imaging Modality using Endocardial Motion,” and were awarded to The Johns Hopkins University (JHU) for its pioneering work on a mathematical software algorithm that utilizes cardiac Computed Tomography (CT) data to determine the regional contractile function of the heart ...

ByCardioWise Inc.


Zucara Therapeutics Secures Grant from GlycoNet to Expand and Validate their Drug Therapy Model for Type 1 Diabetes to Type 2 Diabetes

Zucara Therapeutics Secures Grant from GlycoNet to Expand and Validate their Drug Therapy Model for Type 1 Diabetes to Type 2 Diabetes

Zucara Therapeutics will match the funding with an additional $85,000 in cash and in-kind contributions, including scientific input, to advance this research. Zucara’s lead drug candidate “ZT-01” is moving towards Phase 1 clinical trials in patients with T1D later this year, after demonstrating efficacy and safety validated in multiple preclinical models of ...

ByZucara Therapeutics Inc.

  • Previous
  • Next
Need help finding the right suppliers?Try XPRT Sourcing. Let the XPRTs do the work for you
Back to top
About Medical XPRT

Medical XPRT is a global marketplace with solutions and suppliers for the medical sector, with product catalogs, articles, industry events, publications & more.

Channels

Solutions

  • Medical Equipment & Supplies
  • Medical Software
  • Medical Training Courses
  • Medical Industry Services
  • Medical Product Applications

Latest

  • Medical Industry News
  • Medical Industry Events

Publications

  • Medical Industry Articles & Case Studies
  • Medical Industry Books and Publications
  • Medical Industry Journals and Magazines
  • Medical Industry Downloads
  • Medical Industry Videos

Companies

  • Medical Industry Suppliers & Manufacturers

  • FAQs
  • Company sitemap
  • Category sitemap
Medical XPRT is part of XPRT Media All Rights Reserved.
Terms
Privacy
  • Medical XPRT RSS List
Our sites:
Environmental XPRT
Agriculture XPRT
Energy XPRT
XPRT